Lanean...
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
INTRODUCTION: Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed. M...
Gorde:
| Argitaratua izan da: | Alzheimers Dement (Amst) |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087978/ https://ncbi.nlm.nih.gov/pubmed/33969172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12179 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|